National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 13640-13641 [2017-04915]
Download as PDF
<![CDATA[
13640
Federal Register / Vol. 82, No. 48 / Tuesday, March 14, 2017 / Notices
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 8, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04918 Filed 3–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 18–19, 2017.
Open: May 18, 2017, 8:00 a.m. to 2:30 p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Research; Administrative and
Program Developments; and Overview of the
NINDS Intramural Program.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A
Convent Drive, Bethesda, MD 20892.
Closed: May 18, 2017, 2:30 p.m. to 4:45
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A
Convent Drive, Bethesda, MD 20892.
Closed: May 18, 2017, 4:45 p.m. to 5:15
p.m.
VerDate Sep<11>2014
17:42 Mar 13, 2017
Jkt 241001
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A
Convent Drive, Bethesda, MD 20892.
Closed: May 19, 2017, 8:00 a.m. to 11:00
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A
Convent Drive, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Director, Division of Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248, finkelsr@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: March 8, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–05005 Filed 3–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Small Business
Applications Urology and Urogynecology.
Date: March 22, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
morrisr@niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR15–068: MultiCenter Clinical Studies Planning
Applications Liver.
Date: March 24, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
morrisr@niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR15–068: MultiCenter Clinical Studies Planning
Applications.
Date: March 28, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
morrisr@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 82, No. 48 / Tuesday, March 14, 2017 / Notices
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 8, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04915 Filed 3–13–17; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Partnerships for
Countermeasures Against Select Pathogens
(R01).
Date: March 31, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G42A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5069,
lrust@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: April 10, 2017.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Tracy A. Shahan, Ph.D.,
MBA, Scientific Review Officer, Scientific
Review Program, Division of Extramural
17:42 Mar 13, 2017
Jkt 241001
Dated: March 7, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04913 Filed 3–13–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Activities, Room #3F31, National Institutes of
Health/NIAID, 5601 Fishers Lane, MSC
79823, Bethesda, MD 20892–9823, (240) 669–
5030, tshahan@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Cooperative
Agreements To Benefit Homeless
Individuals (CABHI) Evaluation Client
& Stakeholder Surveys (OMB No. 0930–
0320)—Revision
SAMHSA is conducting a cross-site
evaluation of the FY2016 cohort of the
CABHI grant program. The CABHI
Evaluation builds on a previous
evaluation of SAMHSA’s 2009–2012
homeless services grant programs (i.e.,
Grants for the Benefit of Homeless
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
13641
Individuals, Services in Supportive
Housing, and CABHI), under which the
approved client and stakeholder data
collection tools were developed and
implemented. SAMHSA is requesting
approval from OMB to revise the burden
inventory, which has been calculated
based on the number of FY2016 CABHI
grantees and potential future cohorts of
grantees to be awarded in FY2017, and
to revise some of the measures used on
current tools. This collection was
previously known as the Cross-Site
Evaluation for the Grants for the Benefit
of Homeless Individuals (GBHI), but is
now known as the CABHI Evaluation
Client & Stakeholder Surveys.
In 2016, SAMHSA awarded 30 CABHI
grants across three levels: States (up to
$1.5 million per year), local
governments (up to $800,000 per year),
and communities (up to $400,000 per
year). The grantees are united by the
goal of enhancing and expanding
infrastructure and capacity for mental
health and substance abuse treatment
and related support services for
individuals experiencing chronic
homelessness or veterans, families, or
youth experiencing homelessness as a
result of these conditions. This is
accomplished through the provision of
permanent supportive housing,
behavioral health treatment, and
recovery support services, and
enrollment in health insurance,
Medicaid, or other mainstream benefit
programs. Potential grantees awarded in
FY2017 will have the same funding
options and grant requirements.
The primary task of the CABHI
evaluation is to conduct a
comprehensive process and outcome
evaluation, addressing questions related
to the implementation of the CABHI
grant projects and the extent to which
they were able to meet the program’s
goals. Process evaluation primarily
represents what is done to and for the
client (e.g., services provided); this
aspect of the evaluation will also
include a focus on structure, or the
resources available in the service
delivery system, which represent the
capacity to deliver quality care, but not
the care itself. The outcome evaluation
will focus on outputs, which are the
most immediate or proximal results of
project activities (e.g., changes in
partner collaboration, the number of
clients enrolled in mainstream benefits),
and client outcomes, particularly those
related to behavioral health and
homelessness and housing instability.
Data collection efforts that will support
the evaluation are described below.
The Client Interview—Baseline and
the Client Interview—6-Month Followup have been developed to provide
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 82, Number 48 (Tuesday, March 14, 2017)]
[Notices]
[Pages 13640-13641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04915]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Small Business
Applications Urology and Urogynecology.
Date: March 22, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, morrisr@niddk.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR15-068: Multi-Center
Clinical Studies Planning Applications Liver.
Date: March 24, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, morrisr@niddk.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR15-068: Multi-Center
Clinical Studies Planning Applications.
Date: March 28, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, morrisr@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes,
[[Page 13641]]
Endocrinology and Metabolic Research; 93.848, Digestive Diseases and
Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology
Research, National Institutes of Health, HHS)
Dated: March 8, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04915 Filed 3-13-17; 8:45 am]
BILLING CODE 4140-01-P
